The anterior cutaneus nerve entrapment syndrome (ACNES). Randomized double blind controlled trial for the diagnosis and treatment of entrapment of the anterior cutaneus nerve through the rectus muscle.

The anterior cutaneus nerve entrapment syndrome (ACNES). Randomized double blind controlled trial for the diagnosis and treatment of entrapment of the anterior cutaneus nerve through the rectus muscle. - ACNES the diagnosis and treatment trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON32058

Enrollment

Registered

2008-09-04

Start date

2008-09-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abdominal wall nerve entrapment ACNES

Interventions

Fase 1, diagnostic: Injection of lidocaine vs saline at the painpoint Fase 2, therapeutic conservative: injection of lidocaine and Kenacort at the painpoint in all patients Fase 3, therapeutic operat

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Localized abdominal wall pain in the rectus muscle positive Carnett sign

Exclusion criteria

Exclusion criteria: Suspected intra-abdominal pain Anticoagulants use

Design outcomes

Primary

Measure	Time frame
The difference in number of patients with a clinically relevant reducion of pain on VAS, 15 min after injection of Lidocain vs saline. The difference in number of patients with a clinically relevant reducion of pain on VAS after neurectomie vs sham operation. A more than 50 % reduction on VAS is considered clinically relevant.	—

Secondary

Measure	Time frame
Fase 1, Diagnostic * the difference in the number of people with longterm painfree result after diagnostic injection (VAS	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)